MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.02.2026
Thermo Fisher Scientific Kurzfristige Verbindlichkeiten 2011-2026 | TMO
Kurzfristige Verbindlichkeiten Jährlich Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.2 B | 13.3 B | 14 B | 17 B | 13.4 B | 10.3 B | 6.2 B | 6.15 B | 7.05 B | 4.87 B | 4.15 B | 5.35 B | 3.13 B | 2.09 B | 3.11 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 17 B | 2.09 B | 8.36 B |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 1.62 | -2.12 % | $ 2.15 M |  USA |
 |
Agilent Technologies
A
|
1.71 B | $ 115.05 | -0.49 % | $ 35 B | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 24.54 | -1.76 % | $ 682 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Illumina
ILMN
|
1.55 B | $ 126.49 | -1.58 % | $ 20.1 B | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 22.26 | 1.88 % | $ 1.19 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 83.21 | -1.08 % | $ 5.62 B | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 15.15 | -2.88 % | $ 458 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 165.64 | -3.26 % | $ 8.21 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 16.89 | -1.29 % | $ 378 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
303 M | $ 82.71 | -6.54 % | $ 10.4 B | USA |
 |
Precipio
PRPO
|
3.75 M | $ 32.25 | 5.05 % | $ 51.8 M | USA |
 |
Personalis
PSNL
|
31.1 M | $ 5.44 | -8.72 % | $ 322 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.93 | - | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 7.15 | -1.72 % | $ 298 M | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 413.83 | -1.79 % | $ 11.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Biomerica
BMRA
|
1.74 M | $ 2.19 | 0.46 % | $ 5.03 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 100.97 | -2.18 % | $ 8.33 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 260.26 | -1.2 % | $ 21.7 B | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.2 | -2.54 % | $ 2 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 120.4 | -4.21 % | $ 5.63 B | USA |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 59.76 | -2.03 % | $ 3.57 B | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 8.86 | 2.85 % | $ 1.13 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.87 | 0.72 % | $ 451 M | USA |
 |
Natera
NTRA
|
310 M | $ 201.83 | -1.25 % | $ 19.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 195.01 | -0.82 % | $ 21.6 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
634 K | - | -16.95 % | $ 1.54 M | USA |